Literature DB >> 14715698

High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonism.

Abdelhamid Benazzouz1, Chun Hwei Tai, Wassilios Meissner, Bernard Bioulac, Erwan Bezard, Christian Gross.   

Abstract

High-frequency stimulation (HFS) of the subthalamic nucleus (STN) alleviates dramatically motor symptoms in Parkinson's disease, and recently it has been suggested that zona incerta (ZI) stimulation might be as beneficial to patients. We used in situ cytochrome oxidase (CoI) mRNA hybridization to investigate and compare the effects of HFS of the STN and the ZI on metabolic activity of the STN, globus pallidus (GP), and substantia nigra reticulata (SNr) in normal rats as well as in rats with 6-hydroxydopamine (6-OHDA) lesion, an animal model of Parkinson's disease. In normal rats, HFS of the STN, as well as of the ZI, induced a significant decrease in CoI mRNA expression within the STN and SNr but an increase within the GP. In 6-OHDA rats, HFS of the STN reversed dopamine denervation-induced changes in the expression of CoI mRNA in the STN, SNr, and GP. Similar results were obtained with HFS of the ZI except for the STN, which showed only a trend toward normalization. These data suggest that the ZI, as well as the STN, are implicated in the functional mechanism of HFS supporting the involvement of GABA transmission for the reduction of neuronal activity in the basal ganglia output structures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715698     DOI: 10.1096/fj.03-0576fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.

Authors:  Jonathan Chetrit; Anne Taupignon; Lionel Froux; Stephanie Morin; Rabia Bouali-Benazzouz; Frédéric Naudet; Nabila Kadiri; Christian E Gross; Bernard Bioulac; Abdelhamid Benazzouz
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  Subthalamic nucleus stimulation in Parkinson's disease : anatomical and electrophysiological localization of active contacts.

Authors:  F Godinho; S Thobois; M Magnin; M Guenot; G Polo; I Benatru; J Xie; A Salvetti; L Garcia-Larrea; E Broussolle; P Mertens
Journal:  J Neurol       Date:  2006-06-20       Impact factor: 4.849

3.  High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat.

Authors:  Christine Winter; Christoph Lemke; Reinhard Sohr; Wassilios Meissner; Daniel Harnack; Georg Juckel; Rudolf Morgenstern; Andreas Kupsch
Journal:  Exp Brain Res       Date:  2007-10-26       Impact factor: 1.972

4.  Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.

Authors:  Yunmin Ding; Jacqueline Restrepo; Lisa Won; Dong-Youn Hwang; Kwang-Soo Kim; Un Jung Kang
Journal:  Neurobiol Dis       Date:  2007-04-10       Impact factor: 5.996

5.  Projections of the basal ganglia to the zona incerta of the dog diencephalon.

Authors:  O G Chivileva; A I Gorbachevskaya
Journal:  Neurosci Behav Physiol       Date:  2008-08-16

6.  Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus.

Authors:  Yasin Temel; Laura J Boothman; Arjan Blokland; Peter J Magill; Harry W M Steinbusch; Veerle Visser-Vandewalle; Trevor Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

7.  Upregulation of neuroglobin expression and changes in serum redox indices in a rat model of middle cerebral artery occlusion.

Authors:  Aijia Shang; Ying Yang; Hangyan Wang; Jing Wang; Xingyi Hang; Zhongfeng Wang; Dingbiao Zhou
Journal:  Mol Med Rep       Date:  2015-04-03       Impact factor: 2.952

8.  Rat subthalamic stimulation: Evaluating stimulation-induced dyskinesias, choosing stimulation currents and evaluating the anti-akinetic effect in the cylinder test.

Authors:  Antti Huotarinen; Sakari Leino; Raimo K Tuominen; Aki Laakso
Journal:  MethodsX       Date:  2019-10-14

Review 9.  Zona incerta as a therapeutic target in Parkinson's disease.

Authors:  Krystyna Ossowska
Journal:  J Neurol       Date:  2019-08-02       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.